A new frailty assessment tool can aid in the prognosis of urologic cancer patients, its inventors say.
OnabotulinumtoxinA (Botox) appears to increase the activity of brain regions involved in sensation and processing of urinary urgency in female patients with neurogenic overactive bladder, says Rose Khavari, MD.
Among 321 scheduled telemedicine visits for patients with neurogenic bladder, the compliance rate was 91%.
Nephron-sparing procedures now have clear advantages over radical nephrectomy for most small renal masses.
Las Vegas—Middle-aged men with erectile dysfunction may benefit from penile microvascular arterial bypass surgery as much as young men do, Boston University researchers reported at the Sexual Medicine Society of North America fall meeting here.
Las Vegas—Most men with erectile dysfunction should be tested for androgen deficiency, according to researchers from the University of Minnesota Medical School, Minneapolis. In their study of men with erectile dysfunction, nearly half had testosterone levels less than 400 ng/dL, but they cautioned that the results did not suggest a cause-effect relationship.
Las Vegas—In a recent trial, men with erectile dysfunction and their partners reported that they were somewhat satisfied with a new wrap-around prosthetic device used to stiffen the men's penises.
Las Vegas—Researchers don't agree on how to measure erectile function and dysfunction, making it difficult to determine the effects of prostate cancer treatment on patients' sex lives, said Johns Hopkins researchers who presented a review of 592 articles at the Sexual Medicine Society of North America fall meeting here.
Las Vegas—An investigational drug that acts on the central nervous system may work as a treatment for female sexual dysfunction (FSD), according to a recent study from New York Presbyterian Hospital/Weill Cornell Medical Center in New York. The drug, bremelanotide, is also being investigated for the treatment of erectile dysfunction in men.
Las Vegas—The best way to treat premature ejaculation (PE) is through a combination of sex therapy and pharmaceutical management, Michael A. Perelman, PhD, argued at the Sexual Medicine Society of North America fall meeting here.